Filing Details
- Accession Number:
- 0001127602-24-020736
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-19 16:09:57
- Reporting Period:
- 2024-07-17
- Accepted Time:
- 2024-07-19 16:09:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239351 | P Stephen Macmillan | 250 Campus Drive Marlborough MA 01752 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-07-17 | 3,672 | $26.21 | 1,161,234 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-07-17 | 3,672 | $80.13 | 1,157,562 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2024-07-17 | 3,672 | $0.00 | 3,672 | $26.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 44,039 | 2024-11-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,146,829 | Indirect | MacMillan Family Trust |
Footnotes
- Transaction pursuant to an existing Rule 10b5-1 trading plan adopted August 30, 2023 to exercise and sell expiring stock options.
- Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
- Includes 349 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $80.00 to $80.29 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- This option to purchase common stock became exercisable in equal installments on each of the first five anniversaries of the grant date, November 7, 2014.
Billionaire Hedge Funds
